Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Return to search results

GEO Series: GSE132116

Title: Histone H2B monoubiquitination regulates heart development via epigenetic control of cilia motility [RNA-Seq]

Summary

Genomic analyses of patients with congenital heart disease (CHD) have identified significant contribution from mutations affecting cilia genes and chromatin remodeling genes; however, the mechanism(s) connecting chromatin remodeling to CHD are unknown. Histone H2B mono-ubiquitination (H2Bub1) is catalyzed by the RNF20 complex consisting of RNF20, RNF40 and UBE2B. Here, we show significant enrichment of loss-of-function mutations affecting H2Bub1 in CHD patients (enrichment=6.01, p=1.67x10-03), some of whom had abnormal laterality associated with cilia dysfunction. In Xenopus, knockdown of rnf20 and rnf40 results in abnormal heart looping, defective development of left-right asymmetry and impaired cilia motility. Rnf20, Rnf40 and Ube2b affect LR patterning and cilia synergistically. Examination of global H2Bub1 level in Xenopus embryos shows that H2Bub1 is developmentally regulated and requires Rnf20. To examine gene-specific H2Bub1, we performed ChIP-seq of mouse ciliated and non-ciliated tissues and showed tissue-specific H2Bub1 marks significantly enriched at cilia genes including the transcription factor Rfx3.  Rnf20 knockdown results in decreased levels of rfx3 mRNA in Xenopus, and exogenous rfx3 can rescue the Rnf20 depletion phenotype. These data suggest that Rnf20 functions at the Rfx3 locus regulating cilia motility and cardiac situs and identify H2Bub1 as an upstream transcriptional regulator controlling tissue-specific expression of cilia genes. Our findings mechanistically link the two functional gene ontologies that have been implicated in human CHD: chromatin remodeling and cilia function.


Contributors: Martina Brueckner, Mustafa Khokha

Experiment Type: Xenopus embryo mRNA profiling in wt (in duplicate) and RNF20 morpholino (in triplicate) at 12 hpf, 13 hpf, 14 hpf, 15 hpf, and 16 hpf

Experiment Reagents: rnf20 MO1.

Phenotypes:
Xla Wt + rnf20 MO + WE NF11 (RNA-Seq (RNA))

Article: XB-ART-56064, PubMed

Source: NCBI GEO, Xenbase Download

Samples: (DEG = Differentially Expressed Genes; GSM = GEO Sample Number)
Sample View GSMs Assay Type
WE - NF11 GSM3844820  GSM3844821  RNA-Seq
Background: Xla.Outbred
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 11  
   WE + rnf20 MO - NF11 DEG GSM3844822  GSM3844823  GSM3844824  RNA-Seq
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection rnf20 MO1 rnf20 (Xla) NF stage 2 (2-cell) blastomere
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 11  
WE - NF11.5 GSM3844825  GSM3844826  RNA-Seq
Background: Xla.Outbred
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 11.5  
   WE + rnf20 MO - NF11.5 DEG GSM3844827  GSM3844828  GSM3844829  RNA-Seq
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection rnf20 MO1 rnf20 (Xla) NF stage 2 (2-cell) blastomere
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 11.5  
WE - NF12 GSM3844830  GSM3844831  RNA-Seq
Background: Xla.Outbred
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 12  
   WE + rnf20 MO - NF12 DEG GSM3844832  GSM3844833  GSM3844834  RNA-Seq
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection rnf20 MO1 rnf20 (Xla) NF stage 2 (2-cell) blastomere
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 12  
WE - NF13 GSM3844835  GSM3844836  RNA-Seq
Background: Xla.Outbred
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 13  
   WE + rnf20 MO - NF13 DEG GSM3844837  GSM3844838  GSM3844839  RNA-Seq
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection rnf20 MO1 rnf20 (Xla) NF stage 2 (2-cell) blastomere
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 13  
WE - NF13 late GSM3844840  GSM3844841  RNA-Seq
Background: Xla.Outbred
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 13  
   WE + rnf20 MO - NF13 late DEG GSM3844842  GSM3844843  GSM3844844  RNA-Seq
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection rnf20 MO1 rnf20 (Xla) NF stage 2 (2-cell) blastomere
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 13  
Select All DEG      Select All 
Xtr   
Xla 

Return to search results